Summary of Study ST000465

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench,, where it has been assigned Project ID PR000357. The data can be accessed directly via it's Project DOI: 10.21228/M8WW32 This work is supported by NIH grant, U2C- DK119886.


Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files
Study IDST000465
Study TitleUniquely Tumor-Selective Englerin A Profoundly Alters Lipid Metabolism in Renal Cell Carcinoma inducing ER-Stress and an Acute Inflammatory Response
Study TypeMetabolomic effect of Englerin A on renal cell carcinoma
Study SummaryThis targeted metabolomic analysis was performed on renal cell carcinoma A498 cells with or without anti-cancer drug Englerin treatment for 24 and 48 h.
University of California, San Diego
DepartmentDepartment of Pediatrics
Last NameBatova
First NameAyse
AddressLa Jolla, CA 92093
Submit Date2016-09-09
Num GroupsTwo groups for 24 h treatment (control and Eglerin treatment) and two groups for 48 h treatment. Each has 4 replicates
Total Subjects16
Analysis Type DetailLC-MS
Release Date2016-12-22
Release Version1
Ayse Batova Ayse Batova application/zip

Select appropriate tab below to view additional metadata details:


Subject type: Human renal cancer cells; Subject species: Homo sapiens (Factor headings shown in green)

mb_sample_id local_sample_id Time Treatment
SA023582624hr Control
SA023583824hr Control
SA023584524hr Control
SA023585724hr Control
SA023586224hr Englerin (100 nM)
SA023587424hr Englerin (100 nM)
SA023588124hr Englerin (100 nM)
SA023589324hr Englerin (100 nM)
SA0235901348hr Control
SA0235911548hr Control
SA0235921648hr Control
SA0235931448hr Control
SA023594948hr Englerin (100 nM)
SA0235951048hr Englerin (100 nM)
SA0235961148hr Englerin (100 nM)
SA0235971248hr Englerin (100 nM)
Showing results 1 to 16 of 16